Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Clay · SciRah

Researcher profile · Semantic Scholar

E. Clay

Share profile

E. Clay — researcher profile on SciRah

h-index: 15
Works: 61
Citations: 691

Most-cited papers

Rapid literature review: definition and methodology
Beata Smela, M. Toumi, Karolina Świerk, C. François +3 more
2023Journal of Market Access & Health Policy137 citations Open access
Semantic Scholar
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
E. Clay, B. Falissard, N. Moore, M. Toumi
2012European Journal of Clinical Pharmacology67 citations Open access
Semantic Scholar
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in France.
C. Chouaid, Lionel Bensimon, E. Clay, A. Millier +3 more
2019Lung Cancer65 citations Open access
Semantic Scholar
Cost-effectiveness analyses using real-world data: an overview of the literature
K. Bowrin, J. Briere, P. Levy, A. Millier +2 more
2019Journal of Medical Economics57 citations Open access
Semantic Scholar
Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe
M. Uhart, H. Bricout, E. Clay, N. Largeron
2016Human Vaccines & Immunotherapeutics53 citations Open access
Semantic Scholar
Economic burden for Alzheimer’s disease in China from 2010 to 2050: a modelling study
E. Clay, Junwen Zhou, Z. Yi, S. Zhai +1 more
2019Journal of Market Access & Health Policy30 citations Open access
Semantic Scholar
Systematic literature reviews over the years
Beata Smela, M. Toumi, Karolina Świerk, K. Gawlik +2 more
2023Journal of Market Access & Health Policy25 citations Open access
Semantic Scholar
Persistence and healthcare utilization associated with the use of buprenorphine/naloxone film and tablet formulation therapy in adults with opioid dependence
E. Clay, A. Khemiri, V. Zah, S. Aballéa +2 more
2014Journal of Medical Economics24 citations Open access
Semantic Scholar
Public health impact and economic benefits of quadrivalent influenza vaccine in Latin America
A. Jamotte, E. Clay, B. Macabeo, A. Caicedo +9 more
2017Human Vaccines & Immunotherapeutics21 citations Open access
Semantic Scholar
Validation of the first quality-of-life measurement for patients with Huntington’s disease: the Huntington Quality of Life Instrument
E. Clay, A. de Nicola, J. Dorey, F. Squitieri +7 more
2012International Clinical Psychopharmacology21 citations
Semantic Scholar
A clinical research practice datalink analysis of antidepressant treatment patterns and health care costs in generalized anxiety disorder.
J. Chollet, D. Saragoussi, E. Clay, C. François
2013Value in Health20 citations Open access
Semantic Scholar
An overview of health technology assessments of gene therapies with the focus on cost-effectiveness models
M. Pochopień, E. Paterak, E. Clay, J. Janik +3 more
2021Journal of Market Access & Health Policy17 citations Open access
Semantic Scholar
The quality of life of Spanish patients with Huntington's disease measured with H-QoL-I and EQ-5D
J. Dorey, E. Clay, A. Khemiri, A. Belhadj +2 more
2016Journal of Market Access & Health Policy17 citations Open access
Semantic Scholar
Cost-effectiveness of pirfenidone compared to all available strategies for the treatment of idiopathic pulmonary fibrosis in France
E. Clay, O. Cristeau, Romain Chafaie, A. Pinta +2 more
2019Journal of Market Access & Health Policy15 citations Open access
Semantic Scholar
Cost analysis of adverse events associated with non-small cell lung cancer management in France
C. Chouaid, Delphine Loirat, E. Clay, A. Millier +4 more
2017ClinicoEconomics and Outcomes Research15 citations Open access
Semantic Scholar
Health related quality of life in patients having schizophrenia negative symptoms – a systematic review
Chiraz Azaiez, A. Millier, C. Lançon, E. Clay +3 more
2018Journal of Market Access & Health Policy14 citations Open access
Semantic Scholar
Further evidence of reliability and validity of the Huntington’s disease quality of life battery for carers: Italian and French translations
A. Aubeeluck, J. Dorey, F. Squitieri, E. Clay +5 more
2013Quality of Life Research13 citations
Semantic Scholar
Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
K. Bowrin, J. Briere, L. Fauchier, C. Coleman +4 more
2020PLoS ONE11 citations Open access
Semantic Scholar
Memantine for treatment of moderate or severe Alzheimer’s disease patients in urban China: clinical and economic outcomes from a health economic model
Shan-Lian Hu, Xin Yu, Sheng-Di Chen, E. Clay +2 more
2015Expert review of pharmacoeconomics & outcomes research10 citations
Semantic Scholar
Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States
C. Asche, E. Clay, E. Kharitonova, V. Zah +2 more
2015Journal of Medical Economics10 citations Open access
Semantic Scholar
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies
M. Pochopień, T. Qiu, S. Aballéa, E. Clay +1 more
2021Expert review of pharmacoeconomics & outcomes research8 citations
Semantic Scholar
Impact of therapy escalation on ambulatory care costs among patients with type 2 diabetes in France
F. Guelfucci, E. Clay, S. Aballéa, R. Lassalle +2 more
2013BMC Endocrine Disorders8 citations Open access
Semantic Scholar
Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis
R. Bauersachs, O. Wu, N. Hawkins, K. Bowrin +3 more
2021Cardiovascular Therapeutics7 citations Open access
Semantic Scholar
Pharmacotherapeutic strategies for patients treated for depression in UK primary care: a database analysis
FX. Lamy, J. Chollet, E. Clay, M. Brignone +2 more
2015Current Medical Research and Opinion4 citations
Semantic Scholar
Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK
E. Clay, A. Jamotte, P. Verhamme, A. Cohen +2 more
2016Journal of Market Access & Health Policy3 citations Open access
Semantic Scholar
Costs of Adverse Events Associated with Cancer Therapies in Non-Small Cell Lung Cancer in France
C. Godard, C. Chouaid, E. Angevin, Delphine Loirat +3 more
20162 citations Open access
Semantic Scholar
The Growing Challenge Of Managing Age-Related Diseases In China: Example Of Alzheimer’s Disease
E. Clay, J. Yan, D. Milea, L. Ge +1 more
20142 citations Open access
Semantic Scholar
Analysis of 'Revolving Door' Patients in Opioid Dependent Patients: the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance Claims.
E. Clay, V. Zah, E. Kharitonova, J. Ruby +2 more
2014Value in Health2 citations Open access
Semantic Scholar
PND38 International Comparison of Huntington Disease (HD) Burden
J. Dorey, N. De Nicola, J. Tedroff, F. Squitieri +7 more
20112 citations Open access
Semantic Scholar
PND29 VALIDATION OF THE HUNTINGTON CLINICAL SELF-REPORTED INSTRUMENT (H-CSRI), A CLINIMETRIC PATIENT ASSESSED SCALE FOR PATIENTS WITH HUNTINGTON'S DISEASE
E. Clay, J. Dorey, M. Toumi, J. Tedroff +3 more
20112 citations Open access
Semantic Scholar
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial
Jean-Baptiste Trouiller, B. Macabeo, Andrew Poll, D. Howard +7 more
2022BMJ Open1 citations Open access
Semantic Scholar
EE283 Cost-Effectiveness Analysis of Cell-Based Therapy for Patients with Non-Alcoholic Fatty Liver Disease
S. Aballéa, P. Karwala, I. Żerda, M. Toumi +4 more
2022Value in Health1 citations Open access
Semantic Scholar
HTA74 Could Artificial Intelligence Support Prediction of Reimbursement Decisions in Scotland? A Pilot Project
Y. Wang, M. Toumi, C. François, A. Millier +3 more
2022Value in Health1 citations Open access
Semantic Scholar
Allocating treatment resources for hepatitis C in the UK: a constrained optimization modelling approach
Ru Han, S. Liang, C. François, S. Aballéa +2 more
2021Journal of Market Access & Health Policy1 citations Open access
Semantic Scholar
PDG12 In the Current COVID Reality, CAN Independent Injection of Somatostatin Snalogues Lead to Greater Health Savings? a Budget IMPACT Analysis in the UK
B. Harrow, O. Cristeau, E. Clay, C. François +2 more
20201 citations Open access
Semantic Scholar
PSS7 COMPARING TWO TREAT-AND-EXTEND ANTI-VEGF REGIMENS FOR MANAGING WET AGE-RELATED MACULAR DEGENERATION - IMPLICATIONS FOR THE NATIONAL HEALTH SYSTEM IN JAPAN
M. Pochopień, M. Palarcyzk, E. Clay, Y. Hikichi +4 more
2019Value in Health1 citations Open access
Semantic Scholar
PCN116 COST-EFFECTIVENESS OF PEMBROLIZUMAB (KEYTRUDA®) PLUS PLATINUM-PEMETREXED FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN FRANCE
C. Chouaid, L. Bensimon, A. Millier, E. Clay +5 more
2019Value in Health1 citations Open access
Semantic Scholar
PSS5 COMPARING TWO TREAT-AND-EXTEND ANTI-VEGF REGIMENS FOR MANAGING WET AGE-RELATED MACULAR DEGENERATION - IMPLICATIONS FOR THE NATIONAL HEALTH SYSTEM IN FRANCE
M. Pochopień, M. Palarcyzk, E. Clay, C. Koerber +3 more
2019Value in Health1 citations Open access
Semantic Scholar
PRM123 - AN OVERVIEW OF OPEN-SOURCE MODELS IN HEALTH ECONOMICS
J. Michalczyk, E. Clay, M. Pochopień, S. Aballéa
2018Value in Health1 citations Open access
Semantic Scholar
PMH45 Health-Related Quality of Life Patient-Reported Outcomes in Schizophrenia
A. Millier, E. Clay, D. Chauhan, M. Toumi
20121 citations Open access
Semantic Scholar
F03 Huntington Quality Of Life Interview (HQOLI): a new huntington's disease-specific quality of life instrument
E. Clay, J. Dorey, J. Tedroff, C. Verny +2 more
2010Journal of Neurology Neurosurgery & Psychiatry1 citations
Semantic Scholar
EE174 Public Health Impact of Switching From a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in Ecuador
I. Żerda, M. Gorecki, E. Clay, W. Garcia +2 more
2022Value in Health0 citations Open access
Semantic Scholar
EE247 Public Health Impact of Switching From a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in the Dominican Republic
I. Żerda, M. Gorecki, E. Clay, J. Brea +4 more
2022Value in Health0 citations Open access
Semantic Scholar
PBI2 Economic Evaluation of GENE Therapies: IMPACT of Alternative Payment Models on Uncertainty Around the Icer
M. Pochopień, E. Clay, A. Skrzeczek, S. Aballéa +1 more
20200 citations Open access
Semantic Scholar
PDG23 BUDGET IMPACT ANALYSIS OF SOMATOSTATIN ANALOGUES IN THE TREATMENT OF GEP-NET AND ACROMEGALY IN THE UK
M. Feuilly, O. Cristeau, E. Clay, C. François +3 more
2019Value in Health0 citations Open access
Semantic Scholar
PBI6 WHAT IS THE APPROPRIATE DISCOUNT RATE IN ECONOMIC EVALUATIONS OF GENE THERAPIES (GT)?
R. Velikanova, E. Clay, K. Thokagevistk, S. Aballéa +1 more
2019Value in Health0 citations Open access
Semantic Scholar
CN5 - COST-EFFECTIVENESS OF PEMBROLIZUMAB VERSUS STANDARD-OF-CARE CHEMOTHERAPIES FOR FIRST-LINE TREATMENT OF PD-L1 POSITIVE (≥50%) METASTATIC NON-SMALL CELL LUNG CANCER IN FRANCE
C. Chouaid, L. Bensimon, E. Clay, A. Millier +3 more
2018Value in Health0 citations Open access
Semantic Scholar
PCV79 - REAL-WORLD COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH VITAMIN K ANTAGONISTS IN THE CONTEXT OF STROKE PREVENTION IN ATRIAL FIBRILLATION IN FRANCE
K. Bowrin, J. Briere, A. Millier, P. Levy +2 more
2018Value in Health0 citations Open access
Semantic Scholar
PRM147 - OPEN-SOURCE MODELS IN HEALTH ECONOMICS: EXPERIENCE BASED ON A DISCRETE EVENT SIMULATION MODEL IN MAJOR DEPRESSIVE DISORDER
E. Clay, A. Vataire, O. Cristeau, S. Aballéa
2018Value in Health0 citations Open access
Semantic Scholar
PRM149 - OPEN-SOURCE DISCRETE EVENT SIMULATION MODEL FOR MAJOR DEPRESSION DISORDER (MDD): AN UPDATE SUITABLE FOR NEW GENERATION TREATMENT?
E. Clay, A. Vataire, O. Cristeau, M. Toumi
2018Value in Health0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Toumi×28
Invite
M. Toumi — researcher profile on SciRah
S. Aballéa×14
Invite
S. Aballéa — researcher profile on SciRah
A. Millier×11
Invite
A. Millier — researcher profile on SciRah
M. Pochopień×7
Invite
M. Pochopień — researcher profile on SciRah

×6

Invite

P. Levy — researcher profile on SciRah

Invite

J. Dorey — researcher profile on SciRah

C. François×5

Invite

C. François — researcher profile on SciRah

Invite

O. Cristeau — researcher profile on SciRah

Invite

C. Chouaid — researcher profile on SciRah

Invite

K. Bowrin — researcher profile on SciRah

F. Squitieri×4

Invite

F. Squitieri — researcher profile on SciRah

Invite

J. Tedroff — researcher profile on SciRah